Biblio

33557 resultats trouvés
C
Bouzigon R, Dupuy O, Tiemessen I, De Nardi M, Bernard J-P, Mihailovic T, Theurot D, Miller EDorota, Lombardi G, Dugue BMichel.  2021.  Cryostimulation for Post-exercise Recovery in Athletes: A Consensus and Position Paper. FRONTIERS IN SPORTS AND ACTIVE LIVING. 3:688828.
Guillot X, Tordi N, Prati C, Verhoeven F, Pazart L, Wendling D.  2017.  Cryotherapy decreases synovial Doppler activity and pain in knee arthritis: A randomized-controlled trial. JOINT BONE SPINE. 84:477-483.
Guillot X, Tordi N, Mourot L, Demougeot C, Dugue B, Prati C, Wendling D.  2014.  Cryotherapy in inflammatory rheumatic diseases: a systematic review. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 10:281-294.
Jazdzewska AMaria, Rewicz T, Mamos T, Wattier R, Bacela-Spychalska K, Grabowski M.  2020.  Cryptic diversity and mtDNA phylogeography of the invasive demon shrimp, Dikerogammarus haemobaphes (Eichwald, 1841), in Europe. NEOBIOTA. :53-86.
Reveillion F, Wattier R, Montuire S, Carvalho LSousa, Bollache L.  2020.  Cryptic diversity within three South American whip spider species (Arachnida, Amblypygi). ZOOLOGICAL RESEARCH. 41:595-598.
Gonzalez-Wevar CA, Gerard K, Rosenfeld S, Saucede T, Naretto J, Diaz A, Morley SA, Brickle P, Poulin E.  2019.  Cryptic speciation in Southern Ocean Aequiyoldia eightsii (Jay, 1839): Mio-Pliocene trans-Drake Passage separation and diversification. PROGRESS IN OCEANOGRAPHY. 174:44-54.
Couette S.  2015.  Cryptic Species and Species Concept in Palaeontology. FOLIA PRIMATOLOGICA. 86:263.
Couette S.  2015.  Cryptic Species and Species Concept in Palaeontology. FOLIA PRIMATOLOGICA. 86:263.
Hamdan N., R. Grand B, Moreau J., Thines L..  2018.  Cryptococcal meningitis in an immunocompetent patient with obstructive hydrocephalus: A case report. NEUROCHIRURGIE. 64:324-326.
Sapin E..  2014.  Cryptorchidism: Guidelines for surgical management. ARCHIVES DE PEDIATRIE. 21:113-117.
Martinot M., Abou-Bacar A., Lamothe M., M. Tebacher A, M. Zadeh M, Dalle F., Favennec L., Costa D., Brunet J., Sellal F..  2020.  Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review. BMC INFECTIOUS DISEASES. 20:257.
Mosnier E, Martin N, Razakandrainibe R, Dalle F, Roux G, Buteux A, Favennec L, Brousse P, Guarmit B, Blanchet D et al..  2018.  Cryptosporidiosis Outbreak in Immunocompetent Children from a Remote Area of French Guiana. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 98:1727-1732.
Verhoeven F, Sondag M, Aubry S, Prati C, Wendling D.  2016.  Crystal related odynophagia. PRESSE MEDICALE. 45:801-802.
Diop MBirame, Diop L, Plasscraud L, Maris T.  2015.  Crystal structure of 2-methyl-1H-imidazol-3-ium aquatrichlorido(oxalato-kappa O-2,O `)stannate(IV). ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 71:520+.
Diop MBirame, Diop L, Plasseraud L, Cattey H.  2016.  Crystal structure of 2-methyl-1H-imidazol-3-ium hydrogen oxalate dihydrate. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 72:1113+.
Chaabene M, Khatyr A, Knorr M, Askri M, Rousselin Y, Kubicki MM.  2016.  Crystal structure of 4,4-dibromo-1-(3,4-dimethoxyphenyl)-2-azabuta-1,3-diene-1-carbonitrile. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 72:1167+.
Diop MBirame, Diop L, Plasseraud L, Maris T.  2016.  Crystal structure of bis(2-methyl-1H-imidazol-3-ium) dihydroxidobis(oxalato-kappa O-2(1),O-2)stannate(IV) monohydrate. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 72:355+.
Sarr M, Diasse-Sarr A, Diop L, Plasseraud L, Cattey H.  2015.  Crystal structure of bis(cyclohexylammonium) diphenyldioxalatostannate(IV). ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 71:151+.
Sarr B, Diop CAbdoul Kha, Sidibe M, Rousselin Y.  2018.  Crystal structure of bis(diisopropylammonium) cis-diiodidobis (oxolato-kappa O-2(1), O-2)stannate (IV). ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 74:502+.
Sarr B, Mbaye A, Diop CAbdoul Kha, Melin F, Hellwig P, Sidibe M, Rousselin Y.  2018.  Crystal structure of bis(diisopropylammonium) molybdate. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 74:1682+.
Hassen LBen Haj, Denden Z, Roussclin Y, Nasri H.  2015.  Crystal structure of diaqua[5,10,15,20-tetrakis(4-methoxyphenyl)porphyrinato-kappa N-4]iron(III) diaqua(18-crown-6)-potassium bis(trifluoromethanesulfonate)-18-crown-6 (1/2). ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 71:M215-U154.
Brieger L, Jourdain I, Knorr M, Strohmann C.  2019.  Crystal structure of dicarbonyl[mu(2)-methylenebis-(diphenylphosphane)-kappa P-2:P `][mu(2)-2-(2,4,5-trimethyl-phenyl)-3-oxoprop-1-ene-1,3-diyl](trinheny l-phosnhane-kappa P)ironplatinum(Fe-Pt)-dichloro-metnane-toluene (1/1/2), [(OC)(2)Fe(mu-dppm)(mu-C(=O. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 75:1902+.
Diallo W, Gueye N, Crochet A, Plasseraud L, Cattey H.  2015.  Crystal structure of dimethylammonium hydrogen oxalate hemi(oxalic acid). ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 71:473+.
Mitrofanov AYu, Rousselin Y.  2018.  Crystal structure of di-mu-hvdroxido-bis{aqua[ethyl(1,10-phenanthrolin-3-yl)pnospnonato-ka ppa N-2,N `]-copper(II)} heptahydrate. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 74:1751+.
Mohamed ASaid, Jourdain I, Knorr M, Brieger L, Strohmann C.  2020.  Crystal structure of {mu(2)-1,2-big(4-methylphenyl-sultanyl]-3-oxoprop-1-ene-1,3-diyl-1 :2 kappa C-2(3):C-1}-dicarbonyl-1 kappa C-2-[mu(2) -methylenebis(dinhenylphosphane)-1:2 kappa P-2:P `] (truphenymnospnane-2 kappa P)-ironplatinum(Fe-Pt), [(OC)(2)Fe(mu. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS. 76:1087+.

Pages